Bayer was ordered by a jury in the U.S. state of Georgia to pay about $2.1 billion to a plaintiff who claimed the company's ...
J.P. Morgan analyst Richard Vosser maintained a Hold rating on Bayer (0P6S – Research Report) today and set a price target of €25.00. The ...
In a statement, Bayer said that after reviewing the data for eliapixant (formerly BAY1817080 ) it had concluded that "the overall benefit no long outweighs the risk" in the drug's four target ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Bayer has filed for approval in the US for elinzanetant as a non-hormonal treatment for menopausal symptoms such as hot flushes, with a rival therapy from Astellas in its sights. The FDA ...
Discover for yourself - whether privately or on business - the first-class service at Bayer 04 Leverkusen and become part of the club under the Bayer Cross. Versatile, multifunctional: in the BayArena ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback